Therapy News and Research

RSS

Abbott receives approval for HUMIRA (Adalimumab) for polyarticular juvenile idiopathic arthritis

Abbott has announced that it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA (adalimumab) as a treatment to reduce signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients four years of age and older.

26 Feb 2008

Surgery for spinal stenosis yields greater benefits over nonsurgical treatments

A research study by orthopedic spine, back and neck surgeon at Rush University Medical Center Dr. Howard An and colleagues found that patients who underwent surgery for spinal stenosis showed significantly more improvement in all primary outcomes than did patients who were treated nonsurgically.

26 Feb 2008

Smoking and pre-eclampsia

Pregnant women who suffer from the high risk condition pre-eclampsia which leads to the death of hundreds of babies every year are putting the lives of their unborn children at significantly increased risk if they continue to smoke during pregnancy.

26 Feb 2008

Small protein discovered that specifically recognizes tumors responding to chemotherapy

A technique that specifically "tags" tumors responding to chemotherapy may offer a new strategy for determining a cancer treatment's effectiveness within days of starting treatment, according to a new study by Vanderbilt-Ingram Cancer Center investigators.

26 Feb 2008

Quality of care for inflammatory bowel disease patients can be improved

Inflammatory bowel disease (IBD) is a chronic recurrent gastrointestinal disease.

26 Feb 2008

Cytori Therapeutics receives positive news on breast reconstruction study

Cytori Therapeutics was informed that positive longer-term follow-up data were presented from an independent, investigator-sponsored breast reconstruction study in Japan.

26 Feb 2008

Unusual case of upper obstructive syndrome

Aorto-duodenal fistulae (ADF) are the most frequent aorto-enteric fistulae (80%) and the most frequent presenting sign of ADF is upper gastrointestinal bleeding (UGI).

25 Feb 2008

Technology to defeat bacterial infections shows positive results

The use of natural controls against serious bacterial infection and superbugs is being led by a UK company. Scientists at Biocontrol Ltd have presented at the Bacteriophage 2008 meeting in Hertfordshire a first look at the results of their initial Phase II clinical trial.

25 Feb 2008

XYNTHA approved for teatment of hemophilia A by FDA

Wyeth Pharmaceuticals, a division of Wyeth ( NYSE:WYE) , announced today that it has received approval from the U.S. Food and Drug Administration for XYNTHA(TM) (Antihemophilic Factor [Recombinant], Plasma/Albumin-Free), a recombinant factor VIII product, for patients with hemophilia A for both the control and prevention of bleeding episodes and surgical prophylaxis.

22 Feb 2008

Alternative treatment method offers effective way to treat Crohn's disease

An international research study, published in The Lancet, has thrown into question the current method of treating Crohn's disease - opening the door to a safer and more effective treatment option for sufferers of the chronic disease.

22 Feb 2008

New proof-of-principle findings that thymic involution can be reversed in humans

Scientists at the Gladstone Institute of Virology and Immunology (GIVI) and the University of California, San Francisco (UCSF) have found that therapy can be used to stimulate the production of vital immune cells, called "T- cells," in adults with HIV infection.

21 Feb 2008

Genetic defect causes immune deficiency and balance disorder

A genetic defect that causes a severe immune deficiency in humans may also produce balance disorders, according to a new study by researchers at the University of Iowa, The Jackson Laboratory and East Carolina University.

21 Feb 2008

Female-to-male transsexuals have higher androgen levels, not polycystic ovary syndrome

Contrary to previous studies, female-to-male transsexuals do not have a higher prevalence of polycystic ovary syndrome (PCOS), though they do have significantly higher androgen levels, according to a new study accepted for publication in the Journal of Clinical Endocrinology & Metabolism (JCEM).

21 Feb 2008

Advanced Cell Technology demonstrates highly efficient process for the generation of high-purity hepatocytes

Advanced Cell Technology, Inc. has reported for the first time a robust and highly efficient process for the generation of high-purity hepatocytes (liver cells).

21 Feb 2008

Aquatic exercise shows benefit for fibromyalgia sufferers

Patients suffering from fibromyalgia could benefit significantly from regular exercise in a heated swimming pool, a study published in the open access journal Arthritis Research & Therapy shows.

21 Feb 2008

Study confirms aprotinin drug increases cardiac surgery death rate

The largest study to date of a controversial cardiac surgery drug shows it increases death rates and damages kidney function, according Duke University Medical Center researchers.

21 Feb 2008

Siemens Healthcare announces exclusive partnership with Prowess Inc.

Siemens Healthcare announces an exclusive partnership with Prowess Inc. to develop advanced radiation oncology treatment planning software for integration into Siemens' linear accelerators.

21 Feb 2008

Annual cancer statistics show substantial declines in mortality rates

The American Cancer Society's annual cancer statistics report finds that death rates from cancer in the United States have decreased by 18.4 percent among men and by 10.5 percent among women since mortality rates began to decline in the early 1990s, which translates to the avoidance of more than half a million cancer deaths (534,500) in the United States.

21 Feb 2008

Endoscopic ultrasound-guided therapy safe for severe gastrointestinal bleeding patients

A new Mayo Clinic study found that endoscopic ultrasound-guided therapy appears to be a safe and effective treatment for patients with severe gastrointestinal bleeding for whom conventional therapies have failed.

21 Feb 2008

$Hormone refractory prostate cancers more likely to spread to other organs$

Hormone refractory prostate cancers more likely to spread to other organs

Prostate cancers that are resistant to androgen deprivation therapy are more invasive and more likely to spread to other organs than androgen dependent prostate cancers, UCLA cancer researchers have found.

21 Feb 2008